Activity of regorafenib in advanced pretreated soft tissue sarcoma: Results of a single-center phase II study.
Andrea MarrariAlexia BertuzziSilvia BozzarelliNicolò GennaroLaura GiordanoVittorio QuagliuoloRita De SanctisSimona SalaLuca BalzariniArmando SantoroPublished in: Medicine (2020)
ClinicalTrials.gov NCT02307500.